| Cardiovascular Disease and Adiposity | Lifetime | 100 | GR 2 | 99.41 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 103 | GR 2 | 99.09 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 169 | GR 3 | 99.10 |
| Cardiovascular Health and Disease Prevention | Lifetime | 159 | GR 4 | 99.08 |
| Biomarkers in Disease Mechanisms | Lifetime | 34 | GR 1 | 98.07 |
| Nitric Oxide and Endothelin Effects | Lifetime | 246 | GR 2 | 98.84 |
| Cardiovascular Function and Risk Factors | Lifetime | 517 | GR 4 | 99.07 |
| Lipoproteins and Cardiovascular Health | Lifetime | 291 | GR 3 | 98.69 |
| Cardiac Imaging and Diagnostics | Lifetime | 715 | GR 4 | 98.90 |
| Blood Pressure and Hypertension Studies | Lifetime | 634 | GR 9 | 98.21 |
| Pericarditis and Cardiac Tamponade | Lifetime | 109 | GR 2 | 96.88 |
| Cardiovascular Issues in Pregnancy | Lifetime | 346 | GR 2 | 97.11 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 135 | GR 1 | 96.56 |
| Coronary Interventions and Diagnostics | Lifetime | 919 | GR 7 | 97.53 |
| Heart Failure Treatment and Management | Lifetime | 819 | GR 6 | 97.22 |
| Acute Myocardial Infarction Research | Lifetime | 870 | GR 2 | 97.47 |
| Cardiac Fibrosis and Remodeling | Lifetime | 285 | GR 3 | 95.96 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 366 | GR 3 | 93.76 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 882 | GR 5 | 96.42 |
| Inflammasome and immune disorders | Lifetime | 848 | GR 8 | 93.47 |
| Apelin-related biomedical research | Lifetime | 939 | GR 4 | 83.57 |
| Aortic Thrombus and Embolism | Lifetime | 341 | GR 4 | 79.69 |
| GDF15 and Related Biomarkers | Lifetime | 688 | GR 7 | 78.33 |
| Heart rate and cardiovascular health | Lifetime | 415 | GR 4 | 78.89 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 919 | GR 7 | 73.94 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 37 | GR 4 | 97.55 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 88 | GR 7 | 94.85 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 133 | GR 4 | 91.94 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 599 | GR 5 | 96.17 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 39 | GR 6 | 91.82 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 32 | GR 1 | 89.34 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 380 | GR 16 | 89.54 |
| Coronary Interventions and Diagnostics | 2021-2025 | 665 | GR 6 | 92.93 |
| Inflammasome and immune disorders | 2021-2025 | 628 | GR 3 | 85.93 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 950 | GR 20 | 85.40 |
| Gastrointestinal motility and disorders | 2021-2025 | 907 | GR 5 | 76.73 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 274 | GR 10 | 66.58 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 785 | GR 12 | 68.38 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 393 | GR 3 | 60.90 |
| GDF15 and Related Biomarkers | 2021-2025 | 593 | GR 4 | 54.38 |
